Robert Sebra | Icahn School of Medicine

Biography

Research Topics

Biomedical Informatics, Cancer, Cancer Genetics, Epigenetics, Gene Expressions, Genetics, Infectious Disease, Molecular Biology, RNA, RNA Splicing & Processing, Stem Cells, Technology & Innovation, Translational Research

Multi-Disciplinary Training Area

Genetics and Genomic Sciences [GGS]

Publications

243

Publications

Selected Publications

Author Correction: A streamlined base editor engineering strategy to reduce bystander editing (Nature Communications, (2025), 16, 1, (8115), 10.1038/s41467-025-63609-6). Izabella Valdez, Ian O’Connor, Divesh Patel, Katherine Gierer, Jan Harrington, Ethan Ellis, Stephen A. Caponetti, Robert P. Sebra, Hillary C. Valley, Kevin Coote, Martin Mense, Samuele G. Marro, Tingting Jiang. Nature Communications

Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease. Annapoorna S. Kini, Yuliya Vengrenyuk, Jia Jia Liu, Keisuke Yasumura, Pruthvi C. Revaiah, Aishwaria Mandava, Hardik Shah, Joseph M. Sweeny, Sahil Khera, Vishal Kapur, Parasuram Melarcode-Krishnamoorthy, Amit Hooda, Shingo Minatoguchi, Nimisha Baruah, Derek A. Pineda, Vivian Chen, Ethan Ellis, Aana Hahn, Prakash Krishnan, Usman Baber, Pedro R. Moreno, Roxana Mehran, Robert Sebra, Eric Boerwinkle, Xiaobo Zhou, Jagat Narula, Samin K. Sharma. JACC: Cardiovascular Imaging

Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer (Clin Cancer Res (2017), 23, (1552-1563), 10.1158/1078-0432.CCR-16-1333). Ying Chen, Sandra Catalina Camacho, Thomas R. Silvers, Albiruni R.A. Razak, Nashat Y. Gabrail, John F. Gerecitano, Eva Kalir, Elena Pereira, Brad R. Evans, Susan J. Ramus, Fei Huang, Nolan Priedigkeit, Estefania Rodriguez, Michael Donovan, Faisal Khan, Tamara Kalir, Robert Sebra, Andrew Uzilov, Rong Chen, Rileen Sinha, Richard Halpert, Jean Noel Billaud, Sharon Shacham, Dilara McCauley, Yosef Landesman, Tami Rashal, Michael Kauffman, Mansoor R. Mirza, Morten Mau-Sørensen, Peter Dottino, John A. Martignetti. Clinical Cancer Research

View All Publications

Office Locations

Icahn (East) Building Floor 14 Room 14-20E

1425 Madison Ave

New York, NY 10029

332-243-0721

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Sebra during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

Panacent Bio

Founder/Co-Founder/Partner

Panacent Bio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Sebra during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

Panacent Bio

Founder/Co-Founder/Partner

Panacent Bio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.